Clinical polymorphism of acute disseminated encephalomyelitis: diagnosis, treatment, long-term prognosis. Lecture with the description of clinical cases
https://doi.org/10.17650/2073-8803-2023-18-1-10-21
Abstract
Acute disseminated encephalomyelitis is an acute autoimmune demyelinating disease that manifests as a widespread polyfocal asymmetric lesions of the central nervous system and, in some cases, optic nerves with the formation of corresponding neurological symptoms. This lecture presents basic information about acute disseminated encephalomyelitis with consideration of 5 clinical cases demonstrating the variety of manifestations of this disease in the practice of a neurologist.
About the Authors
V. E. Avdeeva
M. F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Russian Federation
Varvara Evgenyevna Avdeeva
61/2 Shchepkina St., Moscow 129110
A. S. Kotov
M. F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Russian Federation
61/2 Shchepkina St., Moscow 129110
References
1. Almaghrabi N., Saab A. Adult onset acute disseminated encephalomyelitis: A case report. Radiol Case Rep 2021;16(9):2469–73. DOI: 10.1016/j.radcr.2021.05.052
2. Anilkumar A.C., Foris L.A., Tadi P. Acute Disseminated Encephalomyelitis. In: StatPearls. Treasure Island: StatPearls Publishing, 2022. Available at: https://www.ncbi.nlm.nih.gov/books/NBK430934/
3. Ayed H., Chaudhary M.W., AlBaradie R., Mir A. Use of cyclophosphamide in a child with fulminant acute disseminated encephalomyelitis. Child Neurol Open 2018;5:2329048X18754631. DOI: 10.1177/2329048X18754631
4. Boesen M.S., Langkilde A.R., Ilginiene J. et al. Oligoclonal bands, age 11-17 years, occipital lesion, and female sex differentiate pediatric multiple sclerosis from acute disseminated encephalomyelitis: A nationwide cohort study. Mult Scler Relat Disord 2022;66:104008. DOI: 10.1016/j.msard.2022.104008
5. Hyun J.W., Huh S.Y., Shin H.J. et al. Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis. Mult Scler 2019;25(4):585–90. DOI: 10.1177/1352458518761186
6. Iype M., Kunju M., Saradakutty G. et al. Short term outcome of ADEM: Results from a retrospective cohort study from South India. Mult Scler Relat Disord 2017;18:128–34. DOI: 10.1016/j.msard.2017.09.018
7. Jarius S., Paul F., Aktas O. et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation 2018;15(1):134. DOI: 10.1186/s12974-018-1144-2
8. Kawanaka Y., Ando K., Ishikura R. et al. Delayed appearance of transient hyperintensity foci on T1-weighted magnetic resonance imaging in acute disseminated encephalomyelitis. Jpn J Radiol 2019;37(4):277–82. DOI: 10.1007/s11604-018-00808-w
9. Ketelslegers I.A., Visser I.E., Neuteboom R.F. et al. Disease course and outcome of acute disseminated encephalomyelitis is more severe in adults than in children. Mult Scler 2011;17(4):441–8. DOI: 10.1177/1352458510390068
10. Kunchok A., Zekeridou A., McKeon A. Autoimmune glial fibrillary acidic protein astrocytopathy. Curr Opin Neurol 2019;32(3):452–8. DOI: 10.1097/WCO.0000000000000676
11. López-Chiriboga A.S., Majed M., Fryer J. et al. Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgGassociated disorders. JAMA Neurol 2018;75(11):1355–63. DOI: 10.1001/jamaneurol.2018.1814
12. Mahapure K.S., Prabhune A.S., Chouvhan A.V. COVID-19-associated acute disseminated encephalomyelitis: A systematic review. Asian J Neurosurg 2021;16(3):457–69. DOI: 10.4103/ajns.AJNS_406_20
13. Makuuchi Y., Nishimoto M., Yamamoto K. et al. Successful treatment with rituximab in acute disseminated encephalomyelitis with whole spinal cord involvement following HLA haploidentical transplantation. Rinsho Ketsueki 2018;59(12):2588–93. DOI: 10.11406/rinketsu.59.2588
14. Manzano G.S., McEntire C.R.S., Martinez-Lage M. et al. Acute disseminated encephalomyelitis and acute hemorrhagic leukoencephalitis following COVID-19: Systematic review and meta-synthesis. Neurol Neuroimmunol Neuroinflamm 2021;8(6):e1080. DOI: 10.1212/NXI.0000000000001080
15. Massa S., Fracchiolla A., Neglia C. et al. Update on acute disseminated encephalomyelitis in children and adolescents. Children (Basel) 2021;8(4):280. DOI: 10.3390/children8040280
16. Mikaeloff Y., Caridade G., Husson B. et al. Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. Eur J Paediatr Neurol 2007;11(2):90–5. DOI: 10.1016/j.ejpn.2006.11.007
17. Narayan R., Simpson A., Fritsche K. et al. MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder. Mult Scler Relat Disord 2018;25:66–72. DOI: 10.1016/j.msard.2018.07.025
18. Narayan R.N., Wang C., Greenberg B.M. Acute disseminated encephalomyelitis (ADEM) and increased intracranial pressure associated with anti-myelin oligodendrocyte glycoprotein antibodies. Pediatr Neurol 2019;99:64–8. DOI: 10.1016/j.pediatrneurol.2019.03.009
19. Paolilo R.B., Deiva K., Neuteboom R. et al. Acute disseminated encephalomyelitis: Current perspectives. Children (Basel) 2020;7(11):210DOI: 10.3390/children7110210
20. Pohl D., Alper G., Van Haren K. et al. Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome. Neurology 2016;87(9 Suppl 2):S38–S45. DOI: 10.1212/WNL.0000000000002825
21. Pruss H. Autoantibodies in neurological disease. Nat Rev Immunol 2021;21(12):798–813. DOI: 10.1038/s41577-021-00543-w
22. Thompson A.J., Banwell B.L., Barkhof F. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17(2):162–73. DOI: 10.1016/S1474-4422(17)30470-2
23. Vogrig A., Janes F., Gigli G.L. et al. Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination. Clin Neurol Neurosurg 2021;208:106839. DOI: 10.1016/j.clineuro.2021.106839
24. Wang C.X. Assessment and management of acute disseminated encephalomyelitis (ADEM) in the pediatric patient. Paediatr Drugs 2021;23(3):213–21. DOI: 10.1007/s40272-021-00441-7
25. Wingerchuk D.M., Banwell B., Bennett J.L. et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85(2):177–89. DOI: 10.1212/WNL.0000000000001729
26. Yamamoto D., Uchiyama T., Ohashi T., Iizuka T. Case of steroidresponsive unilateral encephalitis with anti-myelin oligodendrocyte glycoprotein antibodies. Neurol Clin Neurosci 2017;5(3):101, 102. DOI: 10.1111/ncn3.12119
27. Yanagida A., Iizuka T., Nagai T. et al. MOG-IgG-positive multifocal myelitis with intrathecal IgG synthesis as a spectrum associated with MOG autoimmunity: two case reports. J Neurol Sci 2017;382:40–3. DOI: 10.1016/j.jns.2017.09.020
28. Zghali M.G. Tumefactive acute disseminated encephalomyelitis. Neurol India 2020;68(1):35–41. DOI: 10.4103/0028-3886.279688
Review
For citations:
Avdeeva V.E., Kotov A.S. Clinical polymorphism of acute disseminated encephalomyelitis: diagnosis, treatment, long-term prognosis. Lecture with the description of clinical cases. Russian Journal of Child Neurology. 2023;18(1):10-21. (In Russ.) https://doi.org/10.17650/2073-8803-2023-18-1-10-21
Views:
672
Email this article 